NASDAQ:ASMB Assembly Biosciences (ASMB) Stock Price, News & Analysis → The new masters of energy (From Porter & Company) (Ad) Free ASMB Stock Alerts $14.28 -1.13 (-7.33%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range$14.28▼$15.9750-Day Range$12.47▼$15.4152-Week Range$7.69▼$20.04Volume17,236 shsAverage Volume24,462 shsMarket Capitalization$78.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Assembly Biosciences alerts: Email Address Assembly Biosciences MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.58% of Float Sold ShortDividend StrengthN/ASustainability-0.71Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$102,979 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($12.65) to ($13.45) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.61 out of 5 starsMedical Sector753rd out of 905 stocksPharmaceutical Preparations Industry359th out of 430 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Assembly Biosciences.Read more about Assembly Biosciences' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.58% of the float of Assembly Biosciences has been sold short.Short Interest Ratio / Days to CoverAssembly Biosciences has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Assembly Biosciences has recently decreased by 14.11%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAssembly Biosciences does not currently pay a dividend.Dividend GrowthAssembly Biosciences does not have a long track record of dividend growth. Previous Next 4.7 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAssembly Biosciences has received a 74.27% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Preclinical research services for physical health", "Clinical research services for infectious diseases", and "Basic medical research services" products. See details.Environmental SustainabilityThe Environmental Impact score for Assembly Biosciences is -0.71. Previous Next 3.3 News and Social Media Coverage News SentimentAssembly Biosciences has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.MarketBeat Follows2 people have added Assembly Biosciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Assembly Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $102,979.00 in company stock.Percentage Held by InsidersOnly 5.10% of the stock of Assembly Biosciences is held by insiders.Percentage Held by InstitutionsOnly 19.92% of the stock of Assembly Biosciences is held by institutions.Read more about Assembly Biosciences' insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Assembly Biosciences are expected to decrease in the coming year, from ($12.65) to ($13.45) per share.Price to Book Value per Share RatioAssembly Biosciences has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Assembly Biosciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. About Assembly Biosciences Stock (NASDAQ:ASMB)Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.Read More ASMB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASMB Stock News HeadlinesMay 25, 2024 | insidertrades.comInsider Selling: Assembly Biosciences, Inc. (NASDAQ:ASMB) Director Sells 2,117 Shares of StockMay 31, 2024 | americanbankingnews.comAssembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest UpdateMay 29, 2024 | msn.comGamecocks to Face IU at Assembly Hall in NovemberMay 29, 2024 | msn.comBrian Nestande, former California Assembly member, died of fentanyl overdose, autopsy saysMay 28, 2024 | msn.comJune 1: Calvary Assembly of God Chicken BBQ & Craft FairMay 28, 2024 | msn.comNATO Parliamentary Assembly calls for Ukraine to be allowed to strike Russia with Western-supplied weaponsMay 27, 2024 | msn.comFrench National Assembly opens debate on assisted suicideMay 27, 2024 | yahoo.comNATO Parliamentary Assembly supports Ukraine's right to hit targets inside Russia using Western armsMay 27, 2024 | msn.comBenue Assembly repeals life pension law for Akume, Suswam, Ortom, othersMay 26, 2024 | msn.comOhio trapped in an abusive relationship with dysfunction Republican-led General AssemblyMay 25, 2024 | msn.comVince Fong resigns from Assembly after CD-20 special election victoryMay 25, 2024 | msn.comSocialist pol running for State Assembly lives in posh NYC condo built with property tax exemption he opposesMay 24, 2024 | msn.comCalifornia bill targeting 'housing-shortage profiteers' by limiting ownership passes AssemblyMay 24, 2024 | yahoo.comDLCC names its spotlight candidates for the Pennsylvania General AssemblyMay 23, 2024 | msn.comPolice cordon off C’River Assembly complex after Speaker’s alleged impeachmentMay 23, 2024 | barrons.comUN General Assembly Establishes Srebrenica Genocide Memorial DayMay 23, 2024 | msn.comReparations proposals for Black Californians advance to state AssemblyMay 23, 2024 | msn.comBill banning legacy admissions in all California colleges and universities passes AssemblyMay 23, 2024 | msn.comWith tighter fiscal times ahead, R.I. Assembly must use surplus wisely in state budgetMay 23, 2024 | barrons.comDR Congo Economy Minister Elected Head Of National AssemblyMay 22, 2024 | globenewswire.comAssembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024May 16, 2024 | finance.yahoo.comAre Medical Stocks Lagging Entera Bio (ENTX) This Year?May 13, 2024 | msn.comAndhra Pradesh Sees 23.1% Voter Turnout in LS Elections, 23% in Assembly Polls by 11 amMay 13, 2024 | investorplace.comASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024May 13, 2024 | msn.comLok Sabha elections 2024: Polling underway for 25 Lok Sabha, 175 Assembly seats in Andhra PradeshSee More Headlines Receive ASMB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/08/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ASMB CUSIP92282210 CIK1426800 Webwww.assemblybio.com Phone(833) 509-4583Fax646-706-5101Employees65Year Founded2005Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-61,230,000.00 Net MarginsN/A Pretax Margin-396.37% Return on Equity-120.58% Return on Assets-54.79% Debt Debt-to-Equity RatioN/A Current Ratio3.02 Quick Ratio3.02 Sales & Book Value Annual Sales$7.16 million Price / Sales10.99 Cash FlowN/A Price / Cash FlowN/A Book Value$7.50 per share Price / Book1.90Miscellaneous Outstanding Shares5,510,000Free Float5,232,000Market Cap$78.68 million OptionableOptionable Beta0.63 Social Links 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jason A. Okazaki (Age 48)CEO, President & Director Comp: $1.07MDr. William E. Delaney IV (Age 52)Ph.D., Chief Scientific Officer Comp: $723.24kDr. Nicole S. White Ph.D.Chief Manufacturing OfficerDr. Uri A. Lopatin M.D. (Age 52)Co-Founder and Clinical & Scientific Advisor Comp: $608.55kDr. Adam ZlotnickCo-Founder, Chief Scientific Advisor and Chair of Hbv & Virology Science Advisory BoardJeanette M BjorkquistExecutive Director of Accounting & TreasuryShannon RyanSenior Vice President of Investor Relations, Corporate Affairs & Alliance ManagementMs. Jennifer A. Troia MHRODSHRM-SCP, SPHR, Chief Human Resources OfficerDr. Anuj Gaggar M.D. (Age 46)Ph.D., Chief Medical Officer Mr. Thomas E. Rollins (Age 68)Executive Officer Comp: $472.55kMore ExecutivesKey CompetitorsStrongbridge BiopharmaNASDAQ:SBBPNektar TherapeuticsNASDAQ:NKTROmerosNASDAQ:OMERCumberland PharmaceuticalsNASDAQ:CPIXLexicon PharmaceuticalsNASDAQ:LXRXView All CompetitorsInsiders & InstitutionsJohn G MchutchisonSold 2,117 sharesTotal: $31,606.81 ($14.93/share)Jason A OkazakiSold 549 sharesTotal: $8,196.57 ($14.93/share)Jeanette M BjorkquistSold 24 sharesTotal: $358.32 ($14.93/share)Vanguard Group Inc.Sold 2,142,720 shares on 5/10/2024Ownership: 3.581%Acadian Asset Management LLCSold 64,552 shares on 5/10/2024Ownership: 0.107%View All Insider TransactionsView All Institutional Transactions ASMB Stock Analysis - Frequently Asked Questions Should I buy or sell Assembly Biosciences stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Assembly Biosciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ASMB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ASMB, but not buy additional shares or sell existing shares. View ASMB analyst ratings or view top-rated stocks. How have ASMB shares performed in 2024? Assembly Biosciences' stock was trading at $9.8412 at the beginning of the year. Since then, ASMB shares have increased by 45.1% and is now trading at $14.28. View the best growth stocks for 2024 here. Are investors shorting Assembly Biosciences? Assembly Biosciences saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 21,300 shares, a decrease of 14.1% from the April 30th total of 24,800 shares. Based on an average trading volume of 19,200 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.6% of the shares of the stock are short sold. View Assembly Biosciences' Short Interest. When is Assembly Biosciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our ASMB earnings forecast. How were Assembly Biosciences' earnings last quarter? Assembly Biosciences, Inc. (NASDAQ:ASMB) released its earnings results on Wednesday, May, 8th. The biopharmaceutical company reported ($1.66) EPS for the quarter, beating the consensus estimate of ($2.74) by $1.08. The biopharmaceutical company had revenue of $5.79 million for the quarter. When did Assembly Biosciences' stock split? Assembly Biosciences shares reverse split before market open on Monday, February 12th 2024. The 1-12 reverse split was announced on Monday, February 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What is John McHutchison's approval rating as Assembly Biosciences' CEO? 8 employees have rated Assembly Biosciences Chief Executive Officer John McHutchison on Glassdoor.com. John McHutchison has an approval rating of 80% among the company's employees. 76.0% of employees surveyed would recommend working at Assembly Biosciences to a friend. What other stocks do shareholders of Assembly Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Assembly Biosciences investors own include BioDelivery Sciences International (BDSI), Exelixis (EXEL), TG Therapeutics (TGTX), Arbutus Biopharma (ABUS), AVEO Pharmaceuticals (AVEO), Sorrento Therapeutics (SRNE), AbbVie (ABBV), BioCryst Pharmaceuticals (BCRX), Gilead Sciences (GILD) and Blueprint Medicines (BPMC). Who are Assembly Biosciences' major shareholders? Assembly Biosciences' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.58%), Marquette Asset Management LLC (0.16%), Acadian Asset Management LLC (0.11%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Alexander Schornstein, Jason A Okazaki, Jeanette M Bjorkquist, John G Mchutchison, Luisa M Stamm, Michael P Samar, Nicole S White and William E Iv Delaney. View institutional ownership trends. How do I buy shares of Assembly Biosciences? Shares of ASMB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ASMB) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assembly Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assembly Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.